Lilly’s Obesity Pill Will Have Far-Reaching Effect, Doctors Say

Eli Lilly & Co.’s obesity pill prompted enough weight loss in a large clinical trial to be meaningful for patients and have far-reaching implications for the field, doctors said. Read More

Eli Lilly's oral GLP-1 pill may help people with Type 2 diabetes lose 'significant' weight, study finds

New data from Eli Lilly says its daily, oral GLP-1 pill may help people who have obesity and people who have Type 2 diabetes lose a significant amount of weight. Read More

Lilly weight-loss pill could be FDA-approved by year-end

Eli Lilly 's experimental weight-loss pill could be fast-tracked under a one- to two-month review process recently launched by the U.S. Food and Drug Administration, several Wall Street analysts said. Read More

Eli Lilly's GLP-1 pill shows promise in weight loss and diabetes trials

So the, the question we're investigating in this study is whether the use of GLP-1 receptor agonists, which is *** medication for weight loss and diabetes, um, is associated with *** lower risk of ... Read More

Eli Lilly, Novo Nordisk prepare to face off in the next obesity drug battleground

Eli Lilly and Novo Nordisk are preparing to take their rivalry to the next frontier of weight-loss medication: pills. Read More

Novo Nordisk’s Drug Trial Achieves 19% Weight Loss, Fuels Rivalry with Eli Lilly

Healthcare company Novo Nordisk ($NVO) has reported promising results from its latest clinical trial for its obesity treatment. Notably, tripling ... Read More

Eli Lilly's oral GLP-1 pill may help people with diabetes lose 'significant' weight

Drugmaker Eli Lilly says its daily oral GLP-1 pill may help people who have obesity and people with Type 2 diabetes lose approximately 23 pounds or more than 10% of their body weight on average, ... Read More